Nova Patents
AT534649T

Imidazothiazoles as p38-kinase-inhibitors

Abstract

The present invention relates to the compound shown by the formula I which has the capability to check p38 by in vivo one or in vitro one.

Term

Term ended

Expired 14 May 2024, 2.4 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

19 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
47073503United States of AmericaP
51229803United States of AmericaP
2004015368United States of AmericaW

Members19

Family members, oldest first
DocumentOfficeKind
AU2004247626A1AustraliaA1
CA2526285A1CanadaA1
WO2004110990A2World Intellectual Property Organization (WIPO)A2
WO2004110990A3World Intellectual Property Organization (WIPO)A3
EP1633758A2European Patent Office (EPO)A2
KR20060025141ARepublic of KoreaA
MXPA05012377AMexicoA
CN1823072AChinaA
JP2006528983AJapanA
US2007270418A1United States of AmericaA1
EP2251343A1European Patent Office (EPO)A1
AU2004247626B2AustraliaB2
US7902192B2United States of AmericaB2
AU2004247626B8AustraliaB8
EP1633758B1European Patent Office (EPO)B1
US2011301160A1United States of AmericaA1
AT534649TThis recordAustriaT
ATE534649T1AustriaT1
JP4939220B2JapanB2